An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
Clinical trial NCT01064414 · COMPLETED
Trial details
- NCT number
- NCT01064414
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-12-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.